India’s Growing CRAMS Sector Faces New Challenges
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - With an estimated annual growth of 25 percent, the Indian contract research and manufacturing services sector is attracting global attention as untapped potential for global pharmaceutical firms, but industry experts say working with India CRAMS brings several challenges